4.5 Article

Minocycline Pretreatment Prevents Blood-Brain Barrier Disruption in Septic Rats

Journal

JOURNAL OF SURGICAL RESEARCH
Volume 273, Issue -, Pages 247-254

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jss.2022.01.021

Keywords

Sepsis; Microglia; Matrix metalloproteinases; Blood-brain barrier; Minocycline

Categories

Funding

  1. Anhui Provincial Special Project of Central Government Guiding Local Science and Technology Development of China [201907d07050001]
  2. Science and Technology Program of Anhui Province [1604f0804043]
  3. Summit Training Program of Yijishan Hospital of Wannan Medical College [GF2019J03]

Ask authors/readers for more resources

The study aimed to investigate the mechanism by which minocycline protects the blood-brain barrier (BBB) in septic rats. The results showed that minocycline pretreatment could inhibit microglial activation, decrease MMP-9 expression, increase the expression of ZO-1 and occludin, and improve the permeability of the BBB.
Introduction: The aim of the study was to explore the mechanism by which minocycline protects the blood-brain barrier (BBB) in septic rats. Methods: A sepsis rat model was generated in healthy, male Sprague-Dawley rats by cecal ligation and puncture (CLP). The rats were randomly divided into four groups and treated as follows: sham-operated plus normal saline (Sham + S group), CLP plus normal saline (CLP + S group), CLP plus minocycline pretreatment (CLP + M1 group), and CLP plus minocycline treatment (CLP + M2 group). Rats in the CLP + M1 group received 45 mg/kg minocycline by intraperitoneal injection every 12 h for 72 h. Rats in the Sham + S and CLP + S groups were injected with the same volume of normal saline every 12 h for 72 h. Rats in the CLP + M2 group were intraperitoneally injected with 45 mg/kg minocycline immediately after CLP and once every 12 h for 72 h. All rats were sacrificed at 72 h after operation. Tumor necrosis factor a and interleukin 6 levels, the expression of ionized calcium-binding adaptor molecule-1 (Iba-1), and the permeability of the BBB were measured. The expression of matrix metalloproteinases-9 (MMP-9) and the tight junction proteins zonula occludens-1 (ZO-1) and occludin was detected by Western blot. In addition, Evans blue (EB) staining, immunohistochemistry, and ELISA analysis were carried out. Results: Minocycline pretreatment significantly inhibited microglial activation, decreased the sepsis-induced expression of MMP-9, increased the expression of ZO-1 and occludin, and improved the permeability of the BBB. Minocycline treatment failed to inhibit microglial activation, decrease the sepsis-induced expression of MMP-9, increase the expression of ZO-1 or occluding, or improve the permeability of the BBB. Conclusions: Minocycline pretreatment can effectively improve the altered permeability of the BBB caused by sepsis. The mechanism may be related to the inhibition of microglial activation and MMP-9 expression and increased expression of ZO-1 and occludin. (C) 2022 The Author(s). Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available